Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Rev ; 43(11): 662-664, 2022 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-36316260
2.
J Perinatol ; 25(7): 463-9, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15889132

RESUMO

BACKGROUND: Inhaled nitric oxide (iNO) is an effective adjunct in the treatment of infants with respiratory failure. Although there are clear benefits to this therapy, potential toxicity could result from reactive nitrosylated species. OBJECTIVE: To evaluate whether iNO therapy is associated with increased serum markers of oxidative stress. DESIGN/METHOD: Multiple markers were prospectively evaluated in the serum of term infants with severe respiratory failure treated with iNO for 1 to 72 hours. These were compared to those of patients exposed to greater than 80% oxygen for more than 6 hours and room air controls. RESULTS: After 24 hours of exposure, the iNO-treated infants had increased serum lipid hydroperoxides (LPO), protein carbonyls and nitrotyrosine residues as well as increased serum total glutathione (GSH) content. The increase in LPO peaked at 24 hours and correlated with the cumulative dose of iNO whereas other markers did not. The presence of chronic lung disease (CLD) did not correlate with serum markers of oxidative injury. CONCLUSIONS: In term infants with respiratory failure, prolonged iNO exposure is associated with a transient increase in markers of oxidative stress, but this finding does not appear to predict the development of CLD.


Assuntos
Broncodilatadores/administração & dosagem , Óxido Nítrico/administração & dosagem , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/fisiologia , Síndrome do Desconforto Respiratório do Recém-Nascido/sangue , Administração por Inalação , Biomarcadores/sangue , Doença Crônica , Feminino , Glutationa/sangue , Humanos , Recém-Nascido , Peróxidos Lipídicos/sangue , Masculino , Estudos Prospectivos , Síndrome do Desconforto Respiratório do Recém-Nascido/tratamento farmacológico , Tirosina/análogos & derivados , Tirosina/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...